Sorrento Therapeutics Investor
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Technology:
CAR-T, Cell_Therapies, RNA
Industry:
CAR-T, RNA
Headquarters:
San Diego, California, United States
Founded Date:
2006-01-01
Employees Number:
101-250
Funding Status:
IPO
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
1
Acquisitions Number:
Made Acquisitions
Investors Number:
1
Total Funding:
185718495
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-10-09
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership